Interventional firm C.R. Bard reported 2004 fiscal third-quarter net sales of $421.9 million, up 17% compared with $361.8 million posted in the same quarter last year.
For the period (end-September 30), the Murray Hill, NJ-based vendor had net income of $102.4 million, a 99% increase compared with net income of $51.5 million a year ago.
Included in the firm's third-quarter 2004 results were certain items that increased net income by $33.8 million. This includes a gain of $30.8 million (after tax) related to the previously announced sale of Bard's endoscopic technologies division.
Excluding the items comprising the $33.8 million one-time gain, the company's net income increased 33% compared with the third quarter of 2003, the company said.
By AuntMinnie.com staff writers
October 20, 2004
Related Reading
Reinsdorf joins Bard, October 15, 2004
ConMed completes Bard endoscopic acquisition, October 1, 2004
Settlement in Immunomedics patent case, September 30, 2004
Bard to unload endoscopic assets, August 18, 2004
Bard ups Q1 forecast, March 10, 2004
Copyright © 2004 AuntMinnie.com
